Who founded NovoPedics?

NovoPedics was founded by Charles J. Gatt, Jr., MD, Michael G. Dunn, PhD.

Who are NovoPedics's investors?

NovoPedics's investors include Foundation Venture Capital Group, LLC.

Where is NovoPedics headquartered?

NovoPedics is headquartered in Monmouth Junction, US.

NovoPedics

Monmouth Junction, US · 1 known investors

NovoPedics is developing MeniscoFix, a resorbable implant placed via arthroscopically-assisted surgery to replace the entire medial or lateral meniscus of the knee, intended to relieve pain, restore mobility, and prevent osteoarthritis in patients with severe meniscal injuries. The device has received FDA Breakthrough Device Designation and supports the growth of new meniscus-like tissue as it resorbs.

Biotech Healthtech Medical Devices

Founders & leadership

Charles J. Gatt, Jr., MDFounder & CEO

Michael G. Dunn, PhDFounder & Secretary/Treasurer

Kevin Weadock, PhDChief Operating Officer

Investors · 1

Foundation Venture Capital Group, LLC✓ verifiedPrinceton · $500K

Competitors · 3

by search overlap

Smith+Nephew6 shared keywordsSmith+Nephew is a medical technology company that develops products for the repair, regeneration, and replacement of soft and hard tissue, including sports medicine solutions for treating sporting injuries. Its technology is used by surgeons to help patients recover and regain mobility.

Vumedi5 shared keywordsVumedi operates a peer-to-peer video education platform where clinicians watch lectures and technique videos across dozens of medical specialties. It partners with academic institutions, hospitals, and life sciences companies to provide continuing medical education content to doctors.

Medpagetoday5 shared keywordsMedPage Today is a clinical news and information platform that provides independent coverage of medical research, healthcare policy, and professional development for U.S. healthcare practitioners. The platform publishes daily clinical news, conference coverage, investigative reports, and podcasts with strict editorial review and fact-checking standards.

Companies competing with NovoPedics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase I	2022	$275.5K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does NovoPedics do?: NovoPedics is developing MeniscoFix, a resorbable implant placed via arthroscopically-assisted surgery to replace the entire medial or lateral meniscus of the knee, intended to relieve pain, restore mobility, and prevent osteoarthritis in patients with severe meniscal injuries. The device has received FDA Breakthrough Device Designation and supports the growth of new meniscus-like tissue as it resorbs.
Who founded NovoPedics?: NovoPedics was founded by Charles J. Gatt, Jr., MD, Michael G. Dunn, PhD.
Who are NovoPedics's investors?: NovoPedics's investors include Foundation Venture Capital Group, LLC.
Where is NovoPedics headquartered?: NovoPedics is headquartered in Monmouth Junction, US.